Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cortexyme
company
About
Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $76M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$99M
Cortexyme has raised a total of
$99M
in funding over 2 rounds. Their latest funding was raised on
May 31, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2018 | Series B | $76M | 3 |
Sequoia Capital
|
— | Detail |
| Apr 14, 2017 | Debt Financing | $8M | 2 | — | — | Detail |
| Jan 6, 2016 | Series A | $15M | 1 |
Pfizer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Cortexyme is funded by 4 investors.
Sequoia Capital
and Verily
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital
|
Yes | Series B |
Verily
|
— | Series B |
|
|
— | Series B |
|
Pfizer
|
— | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
